Clinical research trials, or studies conducted by research professionals to test the safety and effectiveness of medications or procedures in development, come with some inherent risk. The tests being conducted are just that – tests. This means that at the time of the trial, the researchers don’t fully understand all of the potential effects of the treatment. However, here’s why paid clinical trials may be worth considering.
Only the best make it to trials
First, only the most promising treatments make it far enough to be in clinical trials with volunteers. Before that, extensive testing and research are done by other means such as in laboratory conditions and simulations.
Studies follow strict guidelines set by the FDA
Second, there are strict rules and guidelines set by the US Food and Drug Administration (FDA). At the website clinicaltrials.gov you can learn more about how participants are protected through a process called informed consent — “a process used by researchers to provide potential and enrolled participants with information about a clinical study. This information helps people decide whether they want to enroll or continue to participate in the study.”
Furthermore, the FDA regularly inspects clinical trial facilities to assure their quality and professionalism.
The need for up front information
Finally, it’s important to choose a research facility that has professional staff that can walk you through every step of the process and whose guidance you feel comfortable with – long before the trial actually starts. DaVita Clinical Research (DCR) has recruiters on call to answer all of your questions about the research facility, the medical professionals, and your time in clinic. Find out more by speaking with a recruiter today!
Disclaimer: Phase 1 (in-patient) clinical trials are not intended to treat a disease or condition. Phase 3 (out-patient) clinical trials may help treat an existing disease or condition. The information presented in this blog may be referring to either a phase 1 clinical trial or to a phase 3 clinical trial or to both. If you contact us regarding a trial, be sure to speak with the recruiter about whether or not the trial is intended to treat a condition.